603882 金域医学
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额311,9151,230,8211,947,8432,087,9711,523,108
投资活动产生之现金流量净额(361,420)(634,534)(848,369)(1,009,618)(634,353)
筹资活动产生之现金流量净额(463,112)(1,062,016)(868,567)(53,033)(214,378)
汇率变动对现金及现金等价物的影响(1,987)7,38738,949(11,458)(3,757)
现金及现金等价物净增加/(减少)(514,603)(458,343)269,8561,013,862670,620
期初现金及现金等价物余额2,449,6742,908,0172,638,1611,624,300953,680
期末现金及现金等价物余额1,935,0712,449,6742,908,0172,638,1611,624,300